Urea plasters for hand-foot syndrome from chemotherapy
Part of Cancer, Skin clinical trials.
This study tests a plaster containing urea to see if it helps treat hand-foot syndrome, a common side effect of chemotherapy that causes redness, swelling, and pain on the hands and feet. It is for people with mild to moderate symptoms who are otherwise doing well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have hand-foot syndrome that is grade 1 or 2 (mild to moderate).
- You are able to take care of yourself (performance status 0, 1, or 2).
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control.
- You are willing to come back for follow-up visits and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a light-based therapy (photobiomodulation) can reduce pain and skin irritation from hand-foot syndrome/hand-foot skin reaction in people getting chemotherapy or targeted medicines. It may help you heal sooner and feel more comfortable while treatment continues.
This study tests a gel called TAR-0520 for hand and foot syndrome, a painful skin condition that can be caused by the chemotherapy drug capecitabine. The gel is applied to the hands and feet to see if it helps prevent or reduce this side effect.
This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.
This study tests whether a topical anti-inflammatory cream (indomethacin) applied preventively to hands and feet can reduce a painful skin side effect called hand-foot syndrome that occurs in advanced liver cancer patients taking sorafenib. If effective, it could help patients tolerate their cancer medication better.
This trial tests if electroacupuncture combined with self-administered acupressure can prevent hand-foot syndrome, a common side effect of the chemotherapy drug capecitabine. It is for people with gastrointestinal or breast cancer who are starting capecitabine for the first time.
This trial tests a traditional Chinese medicine hand-foot soak to help with painful side effects of cancer treatment, like hand-foot syndrome and nerve damage in hands or feet. If it works, it could make daily activities more comfortable and improve your quality of life.
Hear when a new HFS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.